Spinal Cord Stimulator Trial Period: What the One-Week "Test Drive" Involves

Spinal Cord Stimulator Trial Period: What the One-Week "Test Drive" Involves

For individuals suffering from chronic, intractable back, leg, or arm pain that has failed to respond to previous surgeries, injections, or oral medications, Spinal Cord Stimulation (SCS) offers an advanced neuromodulation option.

One of the greatest advantages of spinal cord stimulation is that it allows patients to complete a temporary, one-week trial—a “test drive”—to evaluate the technology’s effectiveness before committing to a permanent device implantation.

What Is a Spinal Cord Stimulator?

A spinal cord stimulator is an implantable device that delivers mild, imperceptible electrical impulses to the dorsal columns of the spinal cord. These electrical signals disrupt chronic pain signals traveling along the spinal cord before they reach the brain, replacing them with a pleasant tingling sensation (paresthesia) or completely neutralizing the pain sensation depending on the stimulation waveform used.

What Happens During the One-Week Trial?

The SCS trial is a minimally invasive, reversible procedure performed in an outpatient setting:

1. Lead Placement: Guided by real-time fluoroscopic (X-ray) imaging, an interventional specialist places two temporary, thin wire leads into the epidural space along the back of the spinal cord through a small needle puncture.
2. External Controller: The leads are taped securely to the skin and connected to an external battery unit worn on a belt or waistband.
3. Custom Programming: The device is programmed to deliver targeted stimulation customized to the precise location of your pain.
4. Normal Living: Over the course of 5 to 7 days, you return home to perform daily routines, monitoring how well the device relieves your pain during normal activities, sitting, standing, and sleeping.

Evaluating Trial Success

The trial period provides objective data to help you and your specialist decide whether to proceed with permanent implantation. A trial is considered successful if you achieve:

• At least a 50% reduction in overall pain intensity.
• Noticeable improvement in daily functional mobility and sleep quality.
• A reduced reliance on daily oral pain medications.

At the conclusion of the trial, the temporary leads are easily removed in the office. If the trial was successful, you can proceed with scheduling a permanent, fully internal device placement.

• Book Online: Visit igeaneuro.com to request a comprehensive diagnostic consultation with our care team.
• Call Our Team Today: Speak directly with our dedicated patient care coordinators at (866) 467-1770.